CVRx receives FDA approval for expanded labeling of Barostim

<p>U.S. annual market opportunity increases based on real world adoption and strength of long-term BeAT-HF data MINNEAPOLIS, Dec. 26, 2023 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the U.S. Food and Drug Administration (FDA) has approved revised Instructions For Use (IFU) for Barostim incorporating key long-term clinical […]</p>
<p>The post <a href="https://forextv.com/top-news/cvrx-receives-fda-approval-for-expanded-labeling-of-barostim/">CVRx receives FDA approval for expanded labeling of Barostim</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>